Bank Nifty: Zone of 19,500-19,700 to act as crucial support
Bank Nifty: Zone of 19,500-19,700 to act as crucial support

Bank Nifty: Zone of 19,500-19,700 to act as crucial support

Vinayak Gangule Article rating: 4.2

The key takeaway from Friday’s session was that Bank Nifty closed above its 20-day EMA for the first time in the last 39 trading sessions. Bank Nifty also managed to close above 23.6 per cent Fibonacci retracement level of its prior downward move (32,613.10-16,116.25) decisively.

Bulls take charge as Sensex surges by more than 900 points
Bulls take charge as Sensex surges by more than 900 points

Bulls take charge as Sensex surges by more than 900 points

DSIJ Intelligence Article rating: No rating

Domestic benchmark indices have ended the week on a positive note today as Sensex zoomed by 3.22 per cent which is 986.11 points to be at the level of 31,588.72 while, Nifty went up by 3.05 per cent which is 273.95 points to the level of 9,266.75.

Kotak Mahindra Bank introduces ‘ATM on wheels
Kotak Mahindra Bank introduces ‘ATM on wheels

Kotak Mahindra Bank introduces ‘ATM on wheels

Avalokita Pandey Article rating: 4.2

Indian private banking company, Kotak Mahindra Bank, announced the launch of ‘ATM on wheels’ facility in and around Mumbai amid the nationwide lockdown caused due to the rapid spread of Coronavirus.

Torrent Pharmaceuticals forms bearish engulfing candle
Torrent Pharmaceuticals forms bearish engulfing candle

Torrent Pharmaceuticals forms bearish engulfing candle

Vinayak Gangule Article rating: 3.9

The stock of Torrent Pharmaceuticals Limited has formed a bearish engulfing candlestick pattern on the weekly timeframe. This pattern is considered to be a bearish reversal pattern and usually occurs at the top of an uptrend.

Zydus Cadila gets USFDA nod for cancer medication
Zydus Cadila gets USFDA nod for cancer medication

Zydus Cadila gets USFDA nod for cancer medication

DSIJ Intelligence Article rating: 4.9

On Friday, Zydus Cadila announced that it has received a final approval from United States Food & Drug Administration to market Erlotinib tablets (US RLD: Tarceva tablets), in the strengths of 25 mg, 100 mg and 150 mg.

March 2020: Stocks witnessing selling pressure
March 2020: Stocks witnessing selling pressure

March 2020: Stocks witnessing selling pressure

DSIJ Intelligence Article rating: 4.3

Every coin has a flip side and mutual funds are no different. Fund managers not only buy but also sell. It becomes equally important to know what they are selling. So, let’s find out.

India's gold demand to hit 3-decade low
India's gold demand to hit 3-decade low

India's gold demand to hit 3-decade low

DSIJ Intelligence Article rating: 3.9

India’s gold consumption in the current year could fall to nearly 50 per cent from its previous year’s level. This could be the lowest level in nearly three decades. 

Ten stocks close to their 52-week low
Ten stocks close to their 52-week low

Ten stocks close to their 52-week low

DSIJ Intelligence Article rating: 3.4

The market opened in the green on April 17, 2020. The previous trading session witnessed the Sensex going up by 222.80 points to end at 30,602.61 and the Nifty was up 67.50 points to close at 8,992.80.

RSS
First29462947294829492951295329542955Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR